PEDIATRICS Vol. 99 No. 3 March 1997, pp. 489-496 (doi:10.1542/10.1542/peds.99.3.489)
This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 99 No. 3 March 1997, pp. 489-496

AMERICAN ACADEMY OF PEDIATRICS:
Revised Guidelines for Prevention of Early-onset Group B Streptococcal (GBS) Infection

Committee on Infectious Diseases and Committee on Fetus and Newborn

In 1992, the Committee on Infectious Diseases and Committee on Fetus and Newborn of the American Academy of Pediatrics provided guidelines for prevention of early-onset group B streptococcal (GBS) disease through intrapartum chemoprophylaxis of selected maternal GBS carriers. The guidelines were based on demonstrated efficacy in randomized, controlled clinical trials and selected only women with GBS colonization who had an obstetric risk factor. The guidelines were controversial and their implementation incomplete. Since 1992, additional data have become available, and experience with the guidelines has been gained in numerous medical centers. Recently, consensus guidelines were developed by obstetricians, pediatricians, family practitioners, and public health authorities and published by the Centers for Disease Control and Prevention. These recommendations are supported by the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics. This statement reviews the selection of pregnant women for chemoprophylaxis and provides an algorithm for management of their newborns.

Key words: >.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
M. K. Van Dyke, C. R. Phares, R. Lynfield, A. R. Thomas, K. E. Arnold, A. S. Craig, J. Mohle-Boetani, K. Gershman, W. Schaffner, S. Petit, et al.
Evaluation of Universal Antenatal Screening for Group B Streptococcus
N. Engl. J. Med., June 18, 2009; 360(25): 2626 - 2636.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Y. Murayama, C. Seki, H. Sakata, K. Sunaoshi, E. Nakayama, S. Iwata, K. Sunakawa, K. Ubukata, and and the Invasive Streptococcal Disease Working Gro
Capsular Type and Antibiotic Resistance in Streptococcus agalactiae Isolates from Patients, Ranging from Newborns to the Elderly, with Invasive Infections
Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2650 - 2653.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Kimura, S. Suzuki, J.-i. Wachino, H. Kurokawa, K. Yamane, N. Shibata, N. Nagano, H. Kato, K. Shibayama, and Y. Arakawa
First Molecular Characterization of Group B Streptococci with Reduced Penicillin Susceptibility
Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2890 - 2897.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
D. L. Church, H. Baxter, T. Lloyd, B. Miller, and S. Elsayed
Evaluation of StrepB Carrot Broth versus Lim Broth for Detection of Group B Streptococcus Colonization Status of Near-Term Pregnant Women
J. Clin. Microbiol., August 1, 2008; 46(8): 2780 - 2782.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. R. Phares, R. Lynfield, M. M. Farley, J. Mohle-Boetani, L. H. Harrison, S. Petit, A. S. Craig, W. Schaffner, S. M. Zansky, K. Gershman, et al.
Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005
JAMA, May 7, 2008; 299(17): 2056 - 2065.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
M T Neto
Group B streptococcal disease in Portuguese infants younger than 90 days
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2008; 93(2): F90 - F93.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M. Busetti, P. D'Agaro, and C. Campello
Group B streptococcus prevalence in pregnant women from North-Eastern Italy: advantages of a screening strategy based on direct plating plus broth enrichment
J. Clin. Pathol., October 1, 2007; 60(10): 1140 - 1143.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. Berardi, L. Lugli, D. Baronciani, R. Creti, K. Rossi, M. Ciccia, L. Gambini, S. Mariani, I. Papa, L. Serra, et al.
Group B Streptococcal Infections in a Northern Region of Italy
Pediatrics, September 1, 2007; 120(3): e487 - e493.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T. Metsvaht, K. Oselin, M.-L. Ilmoja, K. Anier, and I. Lutsar
Pharmacokinetics of Penicillin G in Very-Low-Birth-Weight Neonates
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 1995 - 2000.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. H. Clark, B. T. Bloom, A. R. Spitzer, and D. R. Gerstmann
Empiric Use of Ampicillin and Cefotaxime, Compared With Ampicillin and Gentamicin, for Neonates at Risk for Sepsis Is Associated With an Increased Risk of Neonatal Death
Pediatrics, January 1, 2006; 117(1): 67 - 74.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
T. S. Glasgow, P. C. Young, J. Wallin, C. Kwok, G. Stoddard, S. Firth, M. Samore, and C. L. Byington
Association of Intrapartum Antibiotic Exposure and Late-Onset Serious Bacterial Infections in Infants
Pediatrics, September 1, 2005; 116(3): 696 - 702.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
U. von Both, A. Buerckstuemmer, K. Fluegge, and R. Berner
Heterogeneity of Genotype-Phenotype Correlation among Macrolide-Resistant Streptococcus agalactiae Isolates
Antimicrob. Agents Chemother., July 1, 2005; 49(7): 3080 - 3082.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
N. Bisharat, N. Jones, D. Marchaim, C. Block, R. M. Harding, P. Yagupsky, T. Peto, and D. W. Crook
Population structure of group B streptococcus from a low-incidence region for invasive neonatal disease
Microbiology, June 1, 2005; 151(6): 1875 - 1881.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
J. S. Heelan, J. Struminsky, P. Lauro, and C. J. Sung
Evaluation of a New Selective Enrichment Broth for Detection of Group B Streptococci in Pregnant Women
J. Clin. Microbiol., February 1, 2005; 43(2): 896 - 897.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
A. C. Rentz, M. H. Samore, G. J. Stoddard, R. G. Faix, and C. L. Byington
Risk Factors Associated With Ampicillin-Resistant Infection in Newborns in the Era of Group B Streptococcal Prophylaxis
Arch Pediatr Adolesc Med, June 1, 2004; 158(6): 556 - 560.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
N. Bisharat, D. W. Crook, J. Leigh, R. M. Harding, P. N. Ward, T. J. Coffey, M. C. Maiden, T. Peto, and N. Jones
Hyperinvasive Neonatal Group B Streptococcus Has Arisen from a Bovine Ancestor
J. Clin. Microbiol., May 1, 2004; 42(5): 2161 - 2167.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
J. S. Heelan, M. E. Hasenbein, and A. J. McAdam
Resistance of Group B Streptococcus to Selected Antibiotics, Including Erythromycin and Clindamycin
J. Clin. Microbiol., March 1, 2004; 42(3): 1263 - 1264.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
U. von Both, M. Ruess, U. Mueller, K. Fluegge, A. Sander, and R. Berner
A Serotype V Clone Is Predominant among Erythromycin-Resistant Streptococcus agalactiae Isolates in a Southwestern Region of Germany
J. Clin. Microbiol., May 1, 2003; 41(5): 2166 - 2169.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. Poyart, L. Jardy, G. Quesne, P. Berche, and P. Trieu-Cuot
Genetic Basis of Antibiotic Resistance in Streptococcus agalactiae Strains Isolated in a French Hospital
Antimicrob. Agents Chemother., February 1, 2003; 47(2): 794 - 797.
[Abstract] [Full Text] [PDF]


Home page
AAP NewsHome page
C. J. Baker and W. P. Kanto Jr.
Implementing new GBS guidelines requires coordinated care
AAP News, February 1, 2003; 22(2): 79 - 86.
[Full Text] [PDF]


Home page
BMJHome page
P. Owen
Prophylaxis for early onset group B streptococcal sepsis is not so effective in practice
BMJ, November 2, 2002; 325(7371): 1037 - 1037.
[Full Text]


Home page
PediatricsHome page
T. B. Hyde, T. M. Hilger, A. Reingold, M. M. Farley, K. L. O'Brien, and A. Schuchat
Trends in Incidence and Antimicrobial Resistance of Early-Onset Sepsis: Population-Based Surveillance in San Francisco and Atlanta
Pediatrics, October 1, 2002; 110(4): 690 - 695.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. A. Haberland, W. E. Benitz, G. D. Sanders, J. B. Pietzsch, S. Yamada, L. Nguyen, and A. M. Garber
Perinatal Screening for Group B Streptococci: Cost-Benefit Analysis of Rapid Polymerase Chain Reaction
Pediatrics, September 1, 2002; 110(3): 471 - 480.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
S. Oddie and N. D Embleton
Risk factors for early onset neonatal group B streptococcal sepsis: case-control study
BMJ, August 10, 2002; 325(7359): 308 - 308.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. J. Schrag, E. R. Zell, R. Lynfield, A. Roome, K. E. Arnold, A. S. Craig, L. H. Harrison, A. Reingold, K. Stefonek, G. Smith, et al.
A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in Neonates
N. Engl. J. Med., July 25, 2002; 347(4): 233 - 239.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
Prevention of group B streptococcal infection in newborns: Recommendation statement from the Canadian Task Force on Preventive Health Care
Can. Med. Assoc. J., April 1, 2002; 166(7): 928 - 930.
[Full Text] [PDF]


Home page
PediatricsHome page
R. S. Baltimore, S. M. Huie, J. I. Meek, A. Schuchat, and K. L. O'Brien
Early-Onset Neonatal Sepsis in the Era of Group B Streptococcal Prevention
Pediatrics, November 1, 2001; 108(5): 1094 - 1098.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
K. Matsubara, Y. Nishiyama, K. Katayama, G. Yamamoto, M. Sugiyama, T. Murai, and K. Baba
Change of antimicrobial susceptibility of group B streptococci over 15 years in Japan
J. Antimicrob. Chemother., October 1, 2001; 48(4): 579 - 582.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
F. Fitoussi, C. Loukil, I. Gros, O. Clermont, P. Mariani, S. Bonacorsi, I. Le Thomas, D. Deforche, and E. Bingen
Mechanisms of Macrolide Resistance in Clinical Group B Streptococci Isolated in France
Antimicrob. Agents Chemother., June 1, 2001; 45(6): 1889 - 1891.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
C. Chiesa, F. Signore, M. Assumma, E. Buffone, P. Tramontozzi, J. F. Osborn, and L. Pacifico
Serial Measurements of C-Reactive Protein and Interleukin-6 in the Immediate Postnatal Period: Reference Intervals and Analysis of Maternal and Perinatal Confounders
Clin. Chem., June 1, 2001; 47(6): 1016 - 1022.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
H. D. Davies, C. E. Adair, A. Schuchat, D. E. Low, R. S. Sauve, and A. McGeer
Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions
Can. Med. Assoc. J., February 1, 2001; 164(4): 479 - 485.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
E. Herting, O. Gefeller, M. Land, L. van Sonderen, K. Harms, B. Robertson, and Members of the Collaborative European Multicenter
Surfactant Treatment of Neonates With Respiratory Failure and Group B Streptococcal Infection
Pediatrics, November 1, 2000; 106(5): 957 - 964.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
B. R. Brodeur, M. Boyer, I. Charlebois, J. Hamel, F. Couture, C. R. Rioux, and D. Martin
Identification of Group B Streptococcal Sip Protein, Which Elicits Cross-Protective Immunity
Infect. Immun., October 1, 2000; 68(10): 5610 - 5618.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Assumma, F. Signore, L. Pacifico, N. Rossi, J. F. Osborn, and C. Chiesa
Serum Procalcitonin Concentrations in Term Delivering Mothers and Their Healthy Offspring: A Longitudinal Study
Clin. Chem., October 1, 2000; 46(10): 1583 - 1587.
[Abstract] [Full Text] [PDF]


Home page
AAP NewsHome page
C. J. Baker
Prophylactic antibiotic use leads to drop in early-onset GBS cases
AAP News, September 28, 2000; 17(4): 154 - 154.
[Full Text] [PDF]


Home page
PediatricsHome page
P. Bromberger, J. M. Lawrence, D. Braun, B. Saunders, R. Contreras, and D. B. Petitti
The Influence of Intrapartum Antibiotics on the Clinical Spectrum of Early-Onset Group B Streptococcal Infection in Term Infants
Pediatrics, August 1, 2000; 106(2): 244 - 250.
[Abstract] [Full Text]


Home page
PediatricsHome page
G. J. Escobar, D.-k. Li, M. A. Armstrong, M. N. Gardner, B. F. Folck, J. E. Verdi, B. Xiong, R. Bergen, and for the Neonatal Infection Study Group
Neonatal Sepsis Workups in Infants >= 2000 Grams at Birth: A Population-Based Study
Pediatrics, August 1, 2000; 106(2): 256 - 263.
[Abstract] [Full Text]


Home page
NEJMHome page
M. G. Bergeron, D. Ke, C. Menard, F. J. Francois, M. Gagnon, M. Bernier, M. Ouellette, P. H. Roy, S. Marcoux, and W. D. Fraser
Rapid Detection of Group B Streptococci in Pregnant Women at Delivery
N. Engl. J. Med., July 20, 2000; 343(3): 175 - 179.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
J. Turow and A. R. Spitzer
Group B Streptococcal Infection Early Onset Disease Controversies in Prevention Guidelines, and Management Strategies for the Neonate
Clinical Pediatrics, June 1, 2000; 39(6): 317 - 326.
[Abstract] [PDF]


Home page
NEJMHome page
S. J. Schrag, S. Zywicki, M. M. Farley, A. L. Reingold, L. H. Harrison, L. B. Lefkowitz, J. L. Hadler, R. Danila, P. R. Cieslak, and A. Schuchat
Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis
N. Engl. J. Med., January 6, 2000; 342(1): 15 - 20.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. Schuchat, S. S. Zywicki, M. J. Dinsmoor, B. Mercer, J. Romaguera, M. J. O'Sullivan, D. Patel, M. T. Peters, B. Stoll, and O. S. Levine
Risk Factors and Opportunities for Prevention of Early-onset Neonatal Sepsis: A Multicenter Case-Control Study
Pediatrics, January 1, 2000; 105(1): 21 - 26.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. E. Hickman, M. A. Rench, P. Ferrieri, and C. J. Baker
Changing Epidemiology of Group B Streptococcal Colonization
Pediatrics, August 1, 1999; 104(2): 203 - 209.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. HERTING, X. GAN, P. RAUPRICH, C. JARSTRAND, and B. ROBERTSON
Combined Treatment with Surfactant and Specific Immunoglobulin Reduces Bacterial Proliferation in Experimental Neonatal Group B Streptococcal Pneumonia
Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1862 - 1867.
[Abstract] [Full Text]


Home page
PediatricsHome page
W. E. Benitz, J. B. Gould, and M. L. Druzin
Preventing Early-onset Group B Streptococcal Sepsis: Strategy Development Using Decision Analysis
Pediatrics, June 1, 1999; 103(6): 76e - 76.
[Abstract] [Full Text]


Home page
PediatricsHome page
W. E. Benitz, J. B. Gould, and M. L. Druzin
Risk Factors for Early-onset Group B Streptococcal Sepsis: Estimation of Odds Ratios by Critical Literature Review
Pediatrics, June 1, 1999; 103(6): 77e - 77.
[Abstract] [Full Text]


Home page
PediatricsHome page
W. E. Benitz, J. B. Gould, and M. L. Druzin
Antimicrobial Prevention of Early-onset Group B Streptococcal Sepsis: Estimates of Risk Reduction Based on a Critical Literature Review
Pediatrics, June 1, 1999; 103(6): 78e - 78.
[Abstract] [Full Text]


Home page
PediatricsHome page
J. C. Mohle-Boetani, T. A. Lieu, G. T. Ray, G. Escobar, and for the Neonatal GBS Prevention Working Group
Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics
Pediatrics, April 1, 1999; 103(4): 703 - 710.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
N. Embleton, U. Wariyar, and E. Hey
Mortality from early onset group B streptococcal infection in the United Kingdom
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 1999; 80(2): 139F - 141.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
D. ISAACS
Prevention of early onset group B streptococcal infection: screen, treat, or observe?
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1998; 79(2): 81F - 82.
[Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
L. M Moses, P T Heath, A R Wilkinson, H E Jeffery, and D Isaacs
Early onset group B streptococcal neonatal infection in Oxford 1985-96
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1998; 79(2): 148F - 149.
[Abstract] [Full Text]


Home page
Clin. Microbiol. Rev.Home page
A. Schuchat
Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms
Clin. Microbiol. Rev., July 1, 1998; 11(3): 497 - 513.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Fernandez, M. E. Hickman, and C. J. Baker
Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or Meningitis
Antimicrob. Agents Chemother., June 1, 1998; 42(6): 1517 - 1519.
[Abstract] [Full Text]


Home page
PediatricsHome page
W. E. Benitz;, S. P. Gotoff, and K. M. Boyer
The Neonatal Group B Streptococcal Debate
Pediatrics, March 1, 1998; 101(3): 494 - 494.
[Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
T. A. Joseph, S. P. Pyati, and N. Jacobs
Neonatal Early-Onset Escherichia coli Disease: The Effect of Intrapartum Ampicillin
Arch Pediatr Adolesc Med, January 1, 1998; 152(1): 35 - 40.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. L. Fenster;, N. A. Halsey, and W. Oh
CDC/AAP/Group B Streptococcal Infections
Pediatrics, January 1, 1998; 101(1): 158 - 158.
[Full Text] [PDF]


Home page
PediatricsHome page
W. Oh and G. Merenstein
Fourth Edition of the Guidelines for Perinatal Care: Summary of Changes
Pediatrics, December 1, 1997; 100(6): 1021 - 1022.
[Full Text] [PDF]


Home page
PediatricsHome page
Y. S. Choi, J. L. Longacre, U. Chesney-Graham, and S. W. Cooper
Revised Group B Streptococcal (GBS) Infection Guidelines
Pediatrics, December 1, 1997; 100(6): 1042 - 1042.
[Full Text] [PDF]


Home page
NEJMHome page
A. Schuchat, K. Robinson, J. D. Wenger, L. H. Harrison, M. Farley, A. L. Reingold, L. Lefkowitz, B. A. Perkins, and The Active Surveillance Team
Bacterial Meningitis in the United States in 1995
N. Engl. J. Med., October 2, 1997; 337(14): 970 - 976.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
N. A. Halsey, A. Schuchat, W. Oh, and C. J. Baker
The 1997 AAP Guidelines for Prevention of Early-onset Group B Streptococcal Disease
Pediatrics, September 1, 1997; 100(3): 383 - 384.
[Full Text] [PDF]